Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × capivasertib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Neoplasm Metastasis 1 Moderate Hepatic Impairment 1 Melanoma 1 Lymphoma 1 Leukemia 1 Healthy Participants 1 Disease Progression 1

Interventions

Magnetic Resonance Spectroscopy 26 Specimen Handling 24 enzalutamide 21 Prednisone 19 Androgen Antagonists 15 Abiraterone Acetate 15 apalutamide 13 Pluvicto 10 darolutamide 9 Radiosurgery 9 Leuprolide 9 X-Rays 8 Radiotherapy 8 Biopsy 8 cabazitaxel 7 abiraterone 7 Photons 7 prednylidene 6 gallium 68 PSMA-11 6 deltacortene 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Glutamate Carboxypeptidase II 6 relugolix 5 luprolide acetate gel depot 5 bicalutamide 5 Goserelin 5 Docetaxel 5 Dexamethasone 5 Carboplatin 5 Brachytherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡